United States (USA) (US)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

3A Fault Tolerant Low Side Driver Circuit Design Using Design FMEA for Automotive Applications (2019) Easwaran SN, Mollat M, Sreedharan D, Camdzic S, Kashvap SV, Weigel R Conference contribution EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS (2019) Perkovic V, Bain S, Bakris G, Buse J, Idorn T, Mahaffey K, Marso S, et al. Conference contribution EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) - A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER (2019) Perkovic V, Bain S, Bakris G, Buse J, Idorn T, Mahaffey K, Marso S, et al. Conference contribution EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER (2019) Perkovic V, Bain S, Bakris G, Buse J, Gondolf T, Idorn T, Lausvig N, et al. Conference contribution Computer science pedagogical content knowledge: Characterizing teacher performance (2019) Yadav A, Berges M Journal article The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis (2019) Ooi BNS, Loh H, Ho PJ, Milne RL, Giles G, Gao C, Kraft P, et al. Journal article LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ARTERITIS: RESULTS FROM PART 2 OF THE GIACTA TRIAL (2019) Stone JH, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES (2019) Schett G, Baraliakos X, Van Den Bosch F, Deodhar A, Gensler LS, Ostergaard M, Agawane S, et al. Conference contribution DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAIVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY (2019) Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Assudani D, et al. Conference contribution MRI-DETECTED STRUCTURAL ABNORMALITIES AND DEVELOPMENT OF INCIDENT RADIOGRAPHIC KNEE OSTEOARTHRITIS OVER 10 YEARS OF FOLLOW-UP (2019) Kwoh CK, Roemer F, Sharma L, Ashbeck E, Hu C, Guermazi A Conference contribution